to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease
A physician consultation is required to determine if GHK-Cu is appropriate for you
5.48]) and a further significant increase at 360 days postoperative ( = 6.57 [3.95
Patients whose only complaint is weight and who have no secondary concerns about skin, hair, inflammation, or tissue quality are better served by optimizing their GLP-1 protocol, adding resistance training, and addressing nutrition rather than adding a peptide that doesnt directly address their primary goal
In rodent brain-injury models, GHK-Cu has been linked to decreased neuronal apoptosis and reduced edema, with one proposed mechanism involving the miR-339-5p/VEGFA pathway, which is active in post-ischemic and hemorrhagic conditions